Pierre Zachée
- Hematology top 0.5%
- Acute Myeloid Leukemia Research 27
- Chronic Myeloid Leukemia Treatments 21
- Hematopoietic Stem Cell Transplantation 17
- Genetics top 0.5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 30
- Chronic Lymphocytic Leukemia Research 20
- Hemoglobinopathies and Related Disorders 12
- Family Practice top 2%
- Rheumatology top 1%
- Eosinophilic Disorders and Syndromes 13
- Nephrology top 2%
-
- Lymphoma Diagnosis and Treatment 11
- Co-authors
- H DemuynckPeter VandenbergheM. BoogaertsAlessandro M. VannucchiRuben A. MesaFrancesco PassamontiJean‐Jacques KiladjianClaire Harrison
- Cited by
- HematologyGeneticsFamily Practice
- Journals
- New England Journal of Medicine (1 paper)Journal of Biological Chemistry (1 paper)Journal of Clinical Oncology (12 papers)
- Partner nations
- BelgiumUnited StatesGermany
In The Last Decade
Pierre Zachée
123 papers receiving 3.9k citations
Hit Papers
Peers
Comparison fields: 5 of 126
- Hematology 1.9k
- Genetics 1.6k
- Family Practice 127
- Rheumatology 819
- Nephrology 253
Countries citing papers authored by Pierre Zachée
This map shows the geographic impact of Pierre Zachée's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Zachée with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Zachée more than expected).
Fields of papers citing papers by Pierre Zachée
This network shows the impact of papers produced by Pierre Zachée. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Zachée. The network helps show where Pierre Zachée may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pierre Zachée, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2023 | 2 | |
| 3 | 2017 | 4 | |
| 4 | Real-world data from 54 Belgian patients from the ponatinib named patient programme (NPP) | 2016 | 1 |
| 5 | 2014 | 6 | |
| 6 | Treatment of peripheral T-cell lymphomas: recommendations of the Belgian Hematological Society (BHS). | 2013 | 0 |
| 7 | 2012 | 82 | |
| 8 | 2008 | 121 | |
| 9 | NONADHERENCE WITH IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA IS A FUNCTION OF DISEASE, HEALTH, KNOWLEDGE, AND SOCIAL FACTORS - RESULTS FROM THE ADAGIO STUDY | 2008 | 3 |
| 10 | Intensive non-myeloablative chemotherapy can induce GvHD and complete remission in patients with AML/MDS relapsing after allo-BMT | 1998 | 1 |
| 11 | Randomized study on hydroxyurea alone versus hydroxyurea combined with low-dose interferon-alpha 2b for chronic myeloid leukemia | 1997 | 42 |
| 12 | Granulocyte-macrophage colony-stimulating factor (GM-CSF) fails to improve outcome in invasive fungal infections in neutropenic cancer patients | 1996 | 1 |
| 13 | Treatment of patients with myelodysplastic syndromes with allogeneic bone marrow transplantation from genotypically HLA-identical sibling and alternative donors. | 1996 | 31 |
| 14 | Intensive chemotherapy followed by autologous progenitor cell transplantation may lead to prolonged hematological and molecular remission in chronic lymphocytic leukemia (CLL) | 1996 | 1 |
| 15 | CML treated by low dose interferon alfa-2B vs hydroxyurea alone: interim report of a multicenter randomized trial | 1995 | 1 |
| 16 | Acute renal failure due to bilateral lymphomatous infiltrates. Primary extranodal non-Hodgkin's lymphoma (p-EN-NHL) of the kidneys: does it really exist? | 1994 | 62 |
| 17 | 1994 | 12 | |
| 18 | 1994 | 12 | |
| 19 | 1991 | 1 | |
| 20 | Nephrotoxicity of Gentamicin in the Human-kidney | 1980 | 6 |
About Pierre Zachée
Pierre Zachée is a scholar working on Hematology, Genetics and Rheumatology, having authored 128 papers that have together received 4.0k indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (30 papers), Acute Myeloid Leukemia Research (27 papers), Chronic Myeloid Leukemia Treatments (21 papers), Chronic Lymphocytic Leukemia Research (20 papers), Hematopoietic Stem Cell Transplantation (17 papers), Eosinophilic Disorders and Syndromes (13 papers), Hemoglobinopathies and Related Disorders (12 papers) and Lymphoma Diagnosis and Treatment (11 papers). The work is most often cited by research in Hematology (1.9k citations), Genetics (1.6k citations) and Family Practice (127 citations). Pierre Zachée has collaborated with scholars based in Belgium, United States and Germany. Frequent co-authors include H Demuynck, Peter Vandenberghe, M. Boogaerts, Alessandro M. Vannucchi, Ruben A. Mesa, Francesco Passamonti, Jean‐Jacques Kiladjian, Claire Harrison, Gregor Verhoef and R. Daelemans. Their work appears in journals such as New England Journal of Medicine, Journal of Biological Chemistry and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.